Europe Epigenetics Market is estimated to reach USD 237.98 million by 2021 | Market Data Forecast

23/giu/2017 08:57:55 MDFtends Contatta l'autore

Questo comunicato è stato pubblicato più di 6 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Epigenetics is the study of changes in gene expression without any change in genetic sequence. These changes are affected by various factors like environment we live in, people we’ve interacted with and our age itself. These Epigenetics create differences in humans making every human unique. Some of these traits can be passed down to future generations.

The Europe Epigenetics Market is expected to grow at a CAGR of 13.2% and reach USD 237.98 million in 2021 from USD 128.03 million in 2016.

Browse market data tables and in-depth TOC of the Europe Epigenetics Market to 2021 @ http://www.marketdataforecast.com/market-reports/europe-epigenetics-market-1971/

Some of the factors like rising prevalence of cancer, increasing funding in R&D, and increasing frequency of research activities are driving the growth of the market. However, lack of trained professionals and high cost of instruments are some of the factors restraining the market.

Europe Epigenetics Market is segmented based on Product and Research Area. Based on Product, market is segmented into Enzymes, Instruments & Consumables, KITS, and Reagents. Based on Research Area, market is segmented into Developmental Biology, Oncology, Drug Delivery. Based on Enzymes, market is further segmented into DNA-Modifying Enzymes, Protein-Modifying Enzymes, RNA-Modifying Enzymes. Further based on Instruments & Consumables, market is segmented into Mass Spectrometers, Next-Generation Sequencers, QPCR, Sonicators, and others. Based on KITS, market is further segmented into Bisulfite Conversion KITS, Chip-Sequence KITS, RNA Sequencing KITS, Whole-Genome Amplification KITS, 5-HMC and 5-MC Analysis KITS, others. Based on Reagents, market is further segmented into Antibodies, buffers, Histones, Magnetic Beads, Primers and others. Oncology segment holds the highest share in the market but drug discovery segment is expected to grow at highest CAGR during Forecast Period.

Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/europe-epigenetics-market-1971/request-sample

Geographically, market is further segmented into Spain, UK, France, Italy and Germany. Europe is the second largest market owing to the stable economy and presence of market leaders.

Major players in the Europe epigenetics market are Abcam plc., Illumina, Inc., QIAGEN N.V., Merck & Co., New England Biolabs, Inc., Sigma-Aldrich Corporation, Thermo Fisher Scientific, Inc., Active Motif, Diagenode, Inc. and Zymo Research Corporation.

Avail discount @ http://www.marketdataforecast.com/market-reports/europe-epigenetics-market-1971/request-discount

About Us:

Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.

Contact:

Abhishek Shukla

Sales Manager (International Business Development)

Market Data Forecast

Direct Line: +1-888-702-9626

Mobile: +91 998 555 0206

Mail: abhishek@marketdataforecast.com

Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/

View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl